Does TISLELIZUMAB Cause Immune-mediated hypophysitis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Immune-mediated hypophysitis have been filed in association with TISLELIZUMAB (TEVIMBRA). This represents 0.1% of all adverse event reports for TISLELIZUMAB.
6
Reports of Immune-mediated hypophysitis with TISLELIZUMAB
0.1%
of all TISLELIZUMAB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Immune-mediated hypophysitis From TISLELIZUMAB?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization.
Is Immune-mediated hypophysitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TISLELIZUMAB Cause?
Myelosuppression (2,142)
White blood cell count decreased (327)
Neutrophil count decreased (277)
Hepatic function abnormal (221)
Pruritus (213)
Rash (208)
Platelet count decreased (183)
Pyrexia (175)
Nausea (165)
Diarrhoea (145)
What Other Drugs Cause Immune-mediated hypophysitis?
NIVOLUMAB (171)
PEMBROLIZUMAB (137)
IPILIMUMAB (135)
CARBOPLATIN (59)
PACLITAXEL (42)
CYCLOPHOSPHAMIDE (33)
EPIRUBICIN (23)
DURVALUMAB (14)
BEVACIZUMAB (12)
DOXORUBICIN (11)
Which TISLELIZUMAB Alternatives Have Lower Immune-mediated hypophysitis Risk?
TISLELIZUMAB vs TISOTUMAB VEDOTIN
TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV
TISLELIZUMAB vs TITANIUM DIOXIDE\ZINC
TISLELIZUMAB vs TIVICAY
TISLELIZUMAB vs TIVOZANIB